Focus Partners Wealth
JAZZ icon

Focus Partners Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

Focus Partners Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Buy
14,917
+5,150
+53% +$900K ﹤0.01% 1162
2025
Q4 		$1.66M Buy
9,767
+5,224
+115% +$801K ﹤0.01% 1408
2025
Q3 		$599K Sell
4,543
-812
-15% -$97.4K ﹤0.01% 1538
2025
Q2 		$568K Buy
5,355
+732
+16% +$79.5K ﹤0.01% 1377
2025
Q1 		$574K Buy
4,623
+145
+3% +$18.9K ﹤0.01% 1286
2024
Q4 		$551K Buy
+4,478
New +$528K ﹤0.01% 1279
2024
Q3 		– Sell
-4,220
Closed -$450K – 1645
2024
Q2 		$450K Buy
4,220
+183
+5% +$20.1K ﹤0.01% 969
2024
Q1 		$445K Buy
+4,037
New +$494K ﹤0.01% 745

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Focus Partners Wealth's JAZZ Position: Q1 2026 in Review

Focus Partners Wealth increased its Jazz Pharmaceuticals (JAZZ) stake by 53% in Q1 2026, buying an estimated $900K and bringing the position to 14,917 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

Focus Partners Wealth first reported a position in JAZZ in Q1 2024 and has held it in 8 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Focus Partners Wealth held 14,917 shares of Jazz Pharmaceuticals worth $2.84M as of Q1 2026.
  • Focus Partners Wealth bought 5,150 Jazz Pharmaceuticals shares in Q1 2026, an estimated $900K.
  • Jazz Pharmaceuticals made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #1162 holding.
  • Focus Partners Wealth first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.